• 1. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 4. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Oxazinanes Morpholines

Ethyl 2-(morpholin-2-yl)acetate hydrochloride: A Comprehensive Overview

Ethyl 2-(morpholin-2-yl)acetate hydrochloride (CAS No. 1992985-32-6) is a significant compound in the realm of pharmaceutical chemistry, exhibiting a unique structural and functional profile that has garnered considerable attention from researchers worldwide. This compound, characterized by its morpholine moiety and ester functional group, has found applications in various biochemical and medicinal research endeavors.

The Ethyl 2-(morpholin-2-yl)acetate hydrochloride molecule is derived from the condensation of morpholine with acetic acid, followed by esterification and subsequent hydrochlorination. This synthetic pathway underscores its versatility as a building block in organic synthesis. The presence of the morpholine ring imparts specific electronic and steric properties to the molecule, making it a valuable candidate for further derivatization and functionalization.

In recent years, the pharmaceutical industry has shown increasing interest in compounds containing the morpholine scaffold due to their potential biological activities. Morpholine derivatives are known for their ability to modulate various biological pathways, including those relevant to neurological disorders, cardiovascular diseases, and infectious diseases. The Ethyl 2-(morpholin-2-yl)acetate hydrochloride structure, with its dual functionality, offers a promising platform for developing novel therapeutic agents.

One of the most compelling aspects of Ethyl 2-(morpholin-2-yl)acetate hydrochloride is its role as an intermediate in the synthesis of more complex pharmacophores. Researchers have leveraged its structural features to create derivatives with enhanced binding affinity and selectivity for target enzymes and receptors. For instance, studies have demonstrated its utility in generating compounds with potential anticonvulsant and anti-inflammatory properties.

The morpholine ring in Ethyl 2-(morpholin-2-yl)acetate hydrochloride contributes to its solubility and bioavailability, which are critical factors in drug development. This characteristic makes it an attractive candidate for formulation into oral or injectable medications. Furthermore, the hydrochloride salt form enhances the compound's stability and shelf life, making it more suitable for industrial-scale production.

Recent advancements in computational chemistry have enabled researchers to predict the biological activity of Ethyl 2-(morpholin-2-yl)acetate hydrochloride with greater accuracy. Molecular docking studies have identified potential interactions between this compound and various biological targets, including kinases, proteases, and ion channels. These findings have opened new avenues for drug discovery and development.

The synthesis of Ethyl 2-(morpholin-2-yl)acetate hydrochloride can be optimized to achieve high yields and purity levels, which are essential for pharmaceutical applications. Modern synthetic techniques, such as catalytic hydrogenation and enzymatic esterification, have improved the efficiency of its production. These advancements not only reduce costs but also minimize environmental impact.

In conclusion, Ethyl 2-(morpholin-2-yl)acetate hydrochloride (CAS No. 1992985-32-6) represents a fascinating compound with significant potential in pharmaceutical research. Its unique structural features and versatile synthetic applications make it a valuable asset in the quest for novel therapeutic agents. As research continues to uncover new biological activities and synthetic pathways, this compound is poised to play an increasingly important role in drug development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)